Summary
This 8-K filing from Edwards Lifesciences Corporation (EW) on July 22, 2003, primarily serves to furnish the company's second-quarter 2003 financial results, which were released via a press release on the same date. While the filing itself does not contain the detailed financial statements, it directs investors to the accompanying press release for the specific figures and operational highlights of the quarter. Investors should refer to this press release for comprehensive information regarding EW's performance during the second quarter of 2003. The report is filed under Item 7 (Financial Statements, Pro Forma Financial Information and Exhibits) and Item 9 (Regulation FD Disclosure), indicating that the press release contains material information intended for public disclosure. The focus is on the dissemination of financial results in compliance with Regulation FD, ensuring all investors have access to the same information simultaneously.
Key Highlights
- 1Edwards Lifesciences (EW) filed a Current Report (8-K) on July 22, 2003.
- 2The primary purpose of the filing is to publicly disclose the company's financial results for the second quarter of 2003.
- 3The financial results were disseminated through a press release issued on the same date, July 22, 2003.
- 4The filing is made under Item 7 (Exhibits) and Item 9 (Regulation FD Disclosure).
- 5Investors are directed to the press release, attached as Exhibit 99, for detailed financial information.
- 6The report ensures compliance with Regulation FD by providing simultaneous public access to material financial information.